Bionano Genomics Reports Second Quarter Revenue of $6.7 Million

Deep News
08/15

During Friday's early trading session, genome analysis scientific instrument company Bionano Genomics (BNGO) raised its 2025 optical genome mapping (OGM) equipment installation target to 25 units, while consumables and software revenue increased by 16%. The company reported second quarter revenue of $6.7 million and is currently focusing on supporting routine users of its optical genome mapping technology.

Bionano is driving business growth by strengthening its software product portfolio.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10